Skip to content
10-K

Annual Report

BioCrude Technologies USA, Inc.

0001731122-26-000496

← back to feed
Filed
Mar 27, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 27, 2026 50.87M sh
Shares Diluted FY 2025 · Dec 31, 2025 50.74M sh
Shares Diluted FY 2025 · Dec 31, 2024 50.86M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$161.37K
Operating Cash Flow FY 2025 · Dec 31, 2024 −$203.73K
Short Term Debt FY 2025 · Dec 31, 2025 $137.24K
Short Term Debt FY 2025 · Dec 31, 2024 $130.64K
Stockholders Equity FY 2025 · Dec 31, 2025 −$467.45K
Stockholders Equity FY 2025 · Dec 31, 2024 −$299.03K
Current Liabilities FY 2025 · Dec 31, 2025 $482.43K
Current Liabilities FY 2025 · Dec 31, 2024 $322.13K
Total Liabilities FY 2025 · Dec 31, 2025 $482.43K
Total Liabilities FY 2025 · Dec 31, 2024 $322.13K
Current Assets FY 2025 · Dec 31, 2025 $1.95K
Current Assets FY 2025 · Dec 31, 2024 $5.2K
Total Assets FY 2025 · Dec 31, 2025 $10.98K
Total Assets FY 2025 · Dec 31, 2024 $19.09K
Eps Diluted FY 2025 · Dec 31, 2025 $0.00
Eps Diluted FY 2025 · Dec 31, 2024 −$0.01
Eps Basic FY 2025 · Dec 31, 2025 $0.00
Eps Basic FY 2025 · Dec 31, 2024 −$0.01
Sga Expense FY 2025 · Dec 31, 2025 $193.98K
Sga Expense FY 2025 · Dec 31, 2024 $277.13K
Net Income FY 2025 · Dec 31, 2025 −$197.44K
Net Income FY 2025 · Dec 31, 2024 −$280.76K
Operating Income FY 2025 · Dec 31, 2025 −$193.98K
Operating Income FY 2025 · Dec 31, 2024 −$277.13K